Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ruja Taffi"'
Autor:
Mauro Silvestrini, M. Danni, Ruja Taffi, Simona Lattanzi, Chiara Rocchi, Raffaella Cerqua, Stella Carletti
Publikováno v:
Multiple sclerosis and related disorders. 45
Background and Purpose Ongoing disease activity during treatment has been associated to worse disability outcomes in patients with Multiple Sclerosis (MS). The aim of this study was to assess the 5-year response to fingolimod (FTY) treatment in patie
Autor:
M. Danni, Simona Lattanzi, Mauro Silvestrini, Chiara Rocchi, Ruja Taffi, Raffaella Cerqua, Maria Cristina Acciarri
Publikováno v:
Multiple sclerosis and related disorders. 44
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system. Although the currently predominant view is that of an autoimmune inflammatory condition, changes in brain vasculature can occur and contribute to pathophysiology. The a
Autor:
Ruja Taffi, M. Danni, Simona Lattanzi, Raffaella Cerqua, Mauro Silvestrini, Leandro Provinciali
Publikováno v:
Journal of the Neurological Sciences. 358:432-434
Purpose The aim of the study was to evaluate whether early disease activity during fingolimod treatment could predict disease progression in patients with relapsing-remitting multiple sclerosis (RRMS). Methods We included RRMS patients who received f
Autor:
Raffaella Cerqua, M. Danni, Alessandra Pulcini, Simona Lattanzi, Ruja Taffi, Mauro Silvestrini, Leandro Provinciali, Giulia Carlini
Publikováno v:
Journal of neurology. 264(11)
Dimethyl fumarate (DMF), fingolimod (FTY) and teriflunomide (TFN) are oral disease-modifying therapies (DMTs) approved for relapsing–remitting multiple sclerosis (RRMS) whose efficacy and tolerability have been separately assessed in phase III tria
Autor:
M. Silvestrini, L. Provinciali, Laura Mazzanti, Francesca Raffaelli, Arianna Vignini, Laura Nanetti, Ruja Taffi
Publikováno v:
Disease Markers, Vol 25, Iss 3, Pp 167-173 (2008)
Disease markers
Scopus-Elsevier
Disease markers
Scopus-Elsevier
Stroke is a heterogeneous syndrome caused by multiple disease mechanisms, resulting in a disruption of cerebral blood flow with subsequent tissue damage. It is well known that erythrocytes have a large amount of sialic acid and could represent a mode
Autor:
Francesca Raffaelli, Arianna Vignini, Marco Bartolini, M. Silvestrini, Laura Nanetti, Ruja Taffi, Leandro Provinciali, Patrizio Pasqualetti, Fabrizio Vernieri, Laura Mazzanti
Publikováno v:
Journal of Neurology. 255:94-98
Production of reactive oxygen species after cerebral blood flow disruption may enhance tissue damage through multiple molecular pathways. Changes in nitric oxide (NO) metabolism and oxidative stress status were investigated in 47 patients with ischem
Autor:
Roberta Luconi, Chiara Lanciotti, Mauro Silvestrini, Laura Mazzanti, Marco Bartolini, Laura Nanetti, Leandro Provinciali, Arianna Vignini, Ruja Taffi
Publikováno v:
Cephalalgia. 25:353-358
Previous investigations have suggested that changes in platelet activity may play a key role in the pathophysiology of migraine via mechanisms involving the nitric oxide (NO) pathway. Changes in platelet response and nitrite levels have recently been
Autor:
Mauro Silvestrini, Ruja Taffi, Roberta Luconi, Marco Bartolini, Laura Mazzanti, Leandro Provinciali, Arianna Vignini
Publikováno v:
Headache. 47(8)
Background and Objective.—The aim of this study was to assess whether the psychological profile may have prognostic significance in chronic migraine patients. Methods.—The Minnesota Multiphasic Personality Inventory-2 was used for the psychologic
Autor:
Laura Nanetti, Ruja Taffi, Tiziana Bacchetti, Cinzia Moroni, Arianna Vignini, Laura Mazzanti, Mauro Silvestrini, Leandro Provinciali, Francesca Raffaelli
Publikováno v:
Molecular and cellular biochemistry. 303(1-2)
Oxidative stress is probably one of the mechanisms involved in neuronal damage induced by ischemia-reperfusion, and the antioxidant activity of plasma may be an important factor providing protection from neurological damage caused by stroke-associate
Autor:
Marco Bartolini, Ruja Taffi, Marianna Capecci, Roberta Luconi, Leandro Provinciali, Chiara Lanciotti, Mreferecauro Silvestrini
Publikováno v:
Clinical neuropharmacology. 28(6)
Objectives: The aim of this study was to compare the efficacy of sodium valproate and topiramate in treating chronic migraine. Methods: Forty-nine patients with chronic migraine were randomly assigned to 1 of 2 groups of treatment: 750 mg/day valproa